These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 23771152)

  • 1. Fibroblast growth factor 21 protects against cardiac hypertrophy in mice.
    Planavila A; Redondo I; Hondares E; Vinciguerra M; Munts C; Iglesias R; Gabrielli LA; Sitges M; Giralt M; van Bilsen M; Villarroya F
    Nat Commun; 2013; 4():2019. PubMed ID: 23771152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibroblast growth factor-21 protects against fibrosis in hypertensive heart disease.
    Ferrer-Curriu G; Redondo-Angulo I; Guitart-Mampel M; Ruperez C; Mas-Stachurska A; Sitges M; Garrabou G; Villarroya F; Fernández-Solà J; Planavila A
    J Pathol; 2019 May; 248(1):30-40. PubMed ID: 30582148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibroblast growth factor 21 protects the heart from angiotensin II-induced cardiac hypertrophy and dysfunction via SIRT1.
    Li S; Zhu Z; Xue M; Yi X; Liang J; Niu C; Chen G; Shen Y; Zhang H; Zheng J; Zhao C; Liang Y; Cong W; Wang Y; Jin L
    Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1241-1252. PubMed ID: 30677512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibroblast growth factor 21 protects the heart from oxidative stress.
    Planavila A; Redondo-Angulo I; Ribas F; Garrabou G; Casademont J; Giralt M; Villarroya F
    Cardiovasc Res; 2015 Apr; 106(1):19-31. PubMed ID: 25538153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sirt1 acts in association with PPARα to protect the heart from hypertrophy, metabolic dysregulation, and inflammation.
    Planavila A; Iglesias R; Giralt M; Villarroya F
    Cardiovasc Res; 2011 May; 90(2):276-84. PubMed ID: 21115502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroblast-mediated pathways in cardiac hypertrophy.
    Fujiu K; Nagai R
    J Mol Cell Cardiol; 2014 May; 70():64-73. PubMed ID: 24492068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reciprocal repression between microRNA-133 and calcineurin regulates cardiac hypertrophy: a novel mechanism for progressive cardiac hypertrophy.
    Dong DL; Chen C; Huo R; Wang N; Li Z; Tu YJ; Hu JT; Chu X; Huang W; Yang BF
    Hypertension; 2010 Apr; 55(4):946-52. PubMed ID: 20177001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fgf21 is required for cardiac remodeling in pregnancy.
    Redondo-Angulo I; Mas-Stachurska A; Sitges M; Tinahones FJ; Giralt M; Villarroya F; Planavila A
    Cardiovasc Res; 2017 Nov; 113(13):1574-1584. PubMed ID: 28472473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletion of soluble epoxide hydrolase attenuates cardiac hypertrophy via down-regulation of cardiac fibroblasts-derived fibroblast growth factor-2.
    Zhang H; Wang T; Zhang K; Liu Y; Huang F; Zhu X; Liu Y; Wang MH; Tang W; Wang J; Huang H
    Crit Care Med; 2014 May; 42(5):e345-54. PubMed ID: 24448199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. STAT3 Suppression Is Involved in the Protective Effect of SIRT6 Against Cardiomyocyte Hypertrophy.
    Zhang X; Li W; Shen P; Feng X; Yue Z; Lu J; You J; Li J; Gao H; Fang S; Li Z; Liu P
    J Cardiovasc Pharmacol; 2016 Sep; 68(3):204-14. PubMed ID: 27124607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ginseng reverses established cardiomyocyte hypertrophy and postmyocardial infarction-induced hypertrophy and heart failure.
    Moey M; Gan XT; Huang CX; Rajapurohitam V; Martínez-Abundis E; Lui EM; Karmazyn M
    Circ Heart Fail; 2012 Jul; 5(4):504-14. PubMed ID: 22576957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NMNAT3 is involved in the protective effect of SIRT3 in Ang II-induced cardiac hypertrophy.
    Yue Z; Ma Y; You J; Li Z; Ding Y; He P; Lu X; Jiang J; Chen S; Liu P
    Exp Cell Res; 2016 Oct; 347(2):261-73. PubMed ID: 27423420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac hypertrophy and histone deacetylase-dependent transcriptional repression mediated by the atypical homeodomain protein Hop.
    Kook H; Lepore JJ; Gitler AD; Lu MM; Wing-Man Yung W; Mackay J; Zhou R; Ferrari V; Gruber P; Epstein JA
    J Clin Invest; 2003 Sep; 112(6):863-71. PubMed ID: 12975471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of fibroblast growth factor 21 in diabetic cardiomyopathy.
    Zhang X; Yang L; Xu X; Tang F; Yi P; Qiu B; Hao Y
    Heart Fail Rev; 2019 Nov; 24(6):1005-1017. PubMed ID: 31175491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth differentiation factor 15 acts anti-apoptotic and pro-hypertrophic in adult cardiomyocytes.
    Heger J; Schiegnitz E; von Waldthausen D; Anwar MM; Piper HM; Euler G
    J Cell Physiol; 2010 Jul; 224(1):120-6. PubMed ID: 20232299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transgenic overexpression of platelet-derived growth factor-C in the mouse heart induces cardiac fibrosis, hypertrophy, and dilated cardiomyopathy.
    Pontén A; Li X; Thorén P; Aase K; Sjöblom T; Ostman A; Eriksson U
    Am J Pathol; 2003 Aug; 163(2):673-82. PubMed ID: 12875986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of fibroblast growth factor 21 on the heart.
    Tanajak P; Chattipakorn SC; Chattipakorn N
    J Endocrinol; 2015 Nov; 227(2):R13-30. PubMed ID: 26341481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autophagic control of cardiac steatosis through FGF21 in obesity-associated cardiomyopathy.
    Rupérez C; Lerin C; Ferrer-Curriu G; Cairo M; Mas-Stachurska A; Sitges M; Villarroya J; Giralt M; Villarroya F; Planavila A
    Int J Cardiol; 2018 Jun; 260():163-170. PubMed ID: 29519677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The protective effect of fibroblast growth factor-21 in alcoholic cardiomyopathy: a role in protecting cardiac mitochondrial function.
    Ferrer-Curriu G; Guitart-Mampel M; Rupérez C; Zamora M; Crispi F; Villarroya F; Fernández-Solà J; Garrabou G; Planavila A
    J Pathol; 2021 Feb; 253(2):198-208. PubMed ID: 33125701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac steroidogenesis and glucocorticoid in the development of cardiac hypertrophy during the progression to heart failure.
    Ohtani T; Mano T; Hikoso S; Sakata Y; Nishio M; Takeda Y; Otsu K; Miwa T; Masuyama T; Hori M; Yamamoto K
    J Hypertens; 2009 May; 27(5):1074-83. PubMed ID: 19349910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.